Teleflex IncorporatedNYSE: TFX

No matter if you invest in value, growth, or momentum, discovering solid stocks is simpler with the Zacks Style Scores, which is a key part of the Zacks Premium research service.

In the third quarter of 2024, TFX enjoys advantages from having a varied range of products, particularly in the Vascular Access and Interventional areas.

Teleflex Incorporated (NYSE:TFX) will hold its Q3 2024 Results Conference Call on October 31, 2024, at 8:00 AM ET. Key company participants include Lawrence Keusch, Liam Kelly, and Thomas Powell, while various analysts from firms like Morgan Stanley and Wells Fargo will also join the call. The operator welcomed everyone and mentioned that the call is being recorded and will be available for replay on the company's website soon.

Teleflex (TFX) reported quarterly earnings of $3.49 per share, which is higher than the Zacks Consensus Estimate of $3.38 per share. This is a decrease compared to earnings of $3.64 per share from the same period last year.

On Thursday, Teleflex, a company that makes surgical equipment, announced that its profits for the third quarter were higher than anticipated, thanks to a strong demand for its medical devices.

WAYNE, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) has announced that its Board of Directors has approved a quarterly cash dividend of $0.34 per share of common stock. This dividend will be paid on December 16, 2024, to shareholders who are on record as of the end of business on November 15, 2024.

WAYNE, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) has released its financial results for the third quarter, which ended on September 29, 2024.

This randomized, controlled study will be the first to provide personalized spacing evidence for patients who experience a recurrence of prostate cancer after surgery. It aims to include these specific patients in its research. This study is significant as it focuses on a unique aspect of treatment for prostate cancer.

WAYNE, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a top global supplier of medical technologies, has introduced two new devices in Canada aimed at improving PICC insertion procedures and minimizing complications. The advanced Arrow™ VPS Rhythm™ DLX Device and NaviCurve™ Stylet are designed to work in tandem, providing Vascular Access professionals with a more efficient and reliable way to place PICCs.